Literature DB >> 18790136

ESI-MS characterization of a novel pyrrole-inosine nucleoside that interacts with guanine bases.

Sarah E Pierce1, Courtney L Sherman, Janarthanan Jayawickramarajah, Candace M Lawrence, Jonathan L Sessler, Jennifer S Brodbelt.   

Abstract

Based on binding studies undertaken by electrospray ionization-mass spectrometry, a synthetic pyrrole-inosine nucleoside, 1, capable of forming an extended three-point Hoogsteen-type hydrogen-bonding interaction with guanine, is shown to form specific complexes with two different quadruplex DNA structures [dTG(4)T](4) and d(T(2)G(4))(4) as well as guanine-rich duplex DNA. The binding interactions of two other analogs were evaluated in order to unravel the structural features that contribute to specific DNA recognition. The importance of the Hoogsteen interactions was confirmed through the absence of specific binding when the pyrrole NH hydrogen-bonding site was blocked or removed. While 2, with a large blocking group, was not found to interact with virtually any form of DNA, 3, with the pyrrole functionality missing, was found to interact non-specifically with several types of DNA. The specific binding of 1 to guanine-rich DNA emphasizes the necessity of careful ligand design for specific sequence recognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790136      PMCID: PMC2593082          DOI: 10.1016/j.aca.2008.04.018

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  30 in total

Review 1.  Transcription factors as targets for DNA-interacting drugs.

Authors:  Marek Gniazdowski; William A Denny; Stephanie M Nelson; Malgorzata Czyz
Journal:  Curr Med Chem       Date:  2003-06       Impact factor: 4.530

2.  Hyperstranded DNA architectures observed by cold-spray ionization mass spectrometry.

Authors:  Shigeru Sakamoto; Kentaro Yamaguchi
Journal:  Angew Chem Int Ed Engl       Date:  2003-02-24       Impact factor: 15.336

3.  Tight binding of the antitumor drug ditercalinium to quadruplex DNA.

Authors:  Carolina Carrasco; Frédéric Rosu; Valérie Gabelica; Claude Houssier; Edwin De Pauw; Christiane Garbay-Jaureguiberry; Bernard Roques; W David Wilson; Jonathan B Chaires; Michael J Waring; Christian Bailly
Journal:  Chembiochem       Date:  2002-12-02       Impact factor: 3.164

4.  Telomestatin-induced stabilization of the human telomeric DNA quadruplex monitored by electrospray mass spectrometry.

Authors:  Frédéric Rosu; Valérie Gabelica; Kazuo Shin-ya; Edwin De Pauw
Journal:  Chem Commun (Camb)       Date:  2003-11-07       Impact factor: 6.222

5.  G-quadruplex formation of thrombin-binding aptamer detected by electrospray ionization mass spectrometry.

Authors:  M Vairamani; Michael L Gross
Journal:  J Am Chem Soc       Date:  2003-01-08       Impact factor: 15.419

6.  Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis.

Authors:  Frederic Rosu; Edwin De Pauw; Lionel Guittat; Patrizia Alberti; Laurent Lacroix; Patrick Mailliet; Jean-François Riou; Jean-Louis Mergny
Journal:  Biochemistry       Date:  2003-09-09       Impact factor: 3.162

Review 7.  Non-covalent ligand/DNA interactions: minor groove binding agents.

Authors:  Stephanie M Nelson; Lynnette R Ferguson; William A Denny
Journal:  Mutat Res       Date:  2007-04-06       Impact factor: 2.433

8.  Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions.

Authors:  Sophie Redon; Sophie Bombard; Miguel-Angel Elizondo-Riojas; Jean-Claude Chottard
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

9.  Investigation of quadruplex oligonucleotide-drug interactions by electrospray ionization mass spectrometry.

Authors:  Wendi M David; Jennifer Brodbelt; Sean M Kerwin; Pei Wang Thomas
Journal:  Anal Chem       Date:  2002-05-01       Impact factor: 6.986

10.  Interactions of cryptolepine and neocryptolepine with unusual DNA structures.

Authors:  Lionel Guittat; Patrizia Alberti; Frédéric Rosu; Sabine Van Miert; Emilie Thetiot; Luc Pieters; Valérie Gabelica; Edwin De Pauw; Alexandre Ottaviani; Jean-François Riou; Jean-Louis Mergny
Journal:  Biochimie       Date:  2003-05       Impact factor: 4.079

View more
  6 in total

1.  Identifying nonspecific ligand binding in electrospray ionization mass spectrometry using the reporter molecule method.

Authors:  Nian Sun; Jiangxiao Sun; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-25       Impact factor: 3.109

2.  ESI mass spectrometric exploration of selective recognition of G-quadruplex in c-myb oncogene promoter using a novel flexible cyclic polyamide.

Authors:  Xiaojie Cui; Qiang Zhang; Han Chen; Jiang Zhou; Gu Yuan
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-23       Impact factor: 3.109

3.  Characterization of aziridinylbenzoquinone DNA cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry.

Authors:  Sarah E Pierce; Lynn J Guziec; Frank S Guziec; Jennifer S Brodbelt
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

Review 4.  Modulation of DNA structure formation using small molecules.

Authors:  Imee M A Del Mundo; Karen M Vasquez; Guliang Wang
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-09-03       Impact factor: 4.739

5.  Evaluation of binding selectivities and affinities of platinum-based quadruplex interactive complexes by electrospray ionization mass spectrometry.

Authors:  Sarah E Pierce; Roxanne Kieltyka; Hanadi F Sleiman; Jennifer S Brodbelt
Journal:  Biopolymers       Date:  2009-04       Impact factor: 2.505

6.  Examination of the effect of the annealing cation on higher order structures containing guanine or isoguanine repeats.

Authors:  Sarah E Pierce; Junmei Wang; Janarthanan Jayawickramarajah; Andrew D Hamilton; Jennifer S Brodbelt
Journal:  Chemistry       Date:  2009-10-26       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.